We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 1,536 results
  1. Setosphapyrone C and D accelerate macrophages cholesterol efflux by promoting LXRα/ABCA1 pathway

    LXRα agonists have attracted significant attention due to their potential biological activities on promoting cholesterol efflux. This study was...

    Ting Li, Jiayu Yin, ... Shoudong Guo in Archives of Pharmacal Research
    Article 10 August 2020
  2. Molecular mechanism of ferulic acid and its derivatives in tumor progression

    Cancer is a significant disease that poses a major threat to human health. The main therapeutic methods for cancer include traditional surgery,...

    **ngxun Bao, Wei Li, ... Lei **a in Pharmacological Reports
    Article Open access 18 May 2023
  3. 2-Geranyl-1-methoxyerythrabyssin II alleviates lipid accumulation and inflammation in hepatocytes through AMPK activation and AKT inhibition

    A growing proportion of the global adult and pediatric populations are currently affected by nonalcoholic steatohepatitis (NASH), leading to rising...

    Yiyuan **, Soeun Kim, ... Namki Cho in Archives of Pharmacal Research
    Article 02 October 2023
  4. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics

    Proton pump inhibitors (PPIs) are the most commonly prescribed drugs for the treatment of non-erosive reflux disease (NERD), ulcers associated with...

    Aneta Kiecka, Marian Szczepanik in Pharmacological Reports
    Article Open access 04 May 2023
  5. Inhibition of Human CYP1A1/A2 by a Hydroalcoholic Extract and Its Neolignan Constituents from Piper rivinoides

    Lignans and neolignans, commonly found in plants, are generally composed of two phenylpropane (C 6 -C 3 ) units with a marked diversity of molecular...

    Carlos Henrique Ramos, Rafael de Oliveira Santos, ... Davyson de Lima Moreira in Revista Brasileira de Farmacognosia
    Article 28 May 2024
  6. Calycosin Inhibits Pulmonary Fibrosis Through the Regulation of miR-375/YAP1 Signaling Pathway

    Pulmonary fibrosis is a chronic lung disease characterized by epithelial-mesenchymal transition. Calycosin, the main active flavonoid isolated from...

    Hui Ji, Linna Guo, ... Haifeng ** in Revista Brasileira de Farmacognosia
    Article 18 October 2022
  7. Dysregulation of histone deacetylases in ocular diseases

    Ocular diseases are a growing global concern and have a significant impact on the quality of life. Cataracts, glaucoma, age-related macular...

    Jae Hyun Jun, Jun-Sik Kim, ... Dong-Gyu Jo in Archives of Pharmacal Research
    Article 27 December 2023
  8. In-Silico Study, Preparation and Biological Evaluation of 99MTC-Mesalamine Complex as Radiotracer for Diagnostics and Monitoring of Ulcerative Colitis in Mice

    This work centralizes on pursuit ulcerative colitis localized in mice. High radiolabeling and purity were ensured during the formation of a...

    M. H. Sanad, S. F. A. Rizvi, ... A. B. Farag in Pharmaceutical Chemistry Journal
    Article 20 September 2022
  9. Treat psoriasis with traditional and novel topical therapies

    The mainstay topical treatments for psoriasis are corticosteroids and/or vitamin D analogues, with retinoids, calcineurin inhibitors, salicylic acid...

    Caroline Fenton, Connie Kang in Drugs & Therapy Perspectives
    Article 05 August 2022
  10. Structural feature of TRAFs, their related human diseases and therapeutic intervention

    Several studies have been conducted over the years to unravel the structural information on the receptors that bind to tumor necrosis factor...

    Article 10 May 2021
  11. M-134, a novel HDAC6-selective inhibitor, markedly improved arthritic severity in a rodent model of rheumatoid arthritis when combined with tofacitinib

    Background

    Although tofacitinib has shown highly significant efficacy for rheumatoid arthritis (RA), there are still a considerable number of patients...

    Daekwon Bae, Youngil Choi, ... Woochan Son in Pharmacological Reports
    Article 13 November 2020
  12. Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway

    Insulin signaling and lipid metabolism are disrupted by long-term consumption of a high-fat diet (HFD). This disruption can lead to insulin...

    Laongdao Thongnak, Nattavadee Pengrattanachot, ... Anusorn Lungkaphin in Archives of Pharmacal Research
    Article 26 March 2023
  13. Pharmacokinetic Study of Tilianin After Oral Administration in Wistar Rats by HPLC

    Tilianin was obtained from the medicinal plant Agastache mexicana (Kunth) Lint & Epling, Lamiaceae, a compound that is candidate to develop new...

    Oswaldo Hernández-Abreu, Samuel Estrada-Soto, ... Rafael Villalobos-Molina in Revista Brasileira de Farmacognosia
    Article 10 April 2024
  14. Anti-angiogenesis revisited: resha** the treatment landscape of advanced non-small cell lung cancer

    Although anti-angiogenic agents have been of limited use in the treatment of non-small cell lung cancer (NSCLC) until recently, further roles for the...

    Sun Ha Choi, Seung Soo Yoo, ... Jae Yong Park in Archives of Pharmacal Research
    Article 21 April 2022
  15. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is a tumor with poor prognosis and frequently aggressive. The development of HCC is associated with fibrosis and...

    Mi Jeong Heo, Jessica Yun, Sang Geon Kim in Archives of Pharmacal Research
    Article 04 January 2019
  16. Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment

    Messenger RNA (mRNA) recently emerged as an appealing alternative to treat and prevent diseases ranging from cancer and Alzheimer’s disease to...

    Md. Emranul Karim, Sheikh Tanzina Haque, ... Ezharul Hoque Chowdhury in Archives of Pharmacal Research
    Article 24 November 2022
  17. Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review

    Cannabinoid receptors, endogenous cannabinoids (endocannabinoids), and the enzymes involved in the biosynthesis and degradation of the...

    Gidion Wilson, Lingling Yang, ... Xueqin Ma in Pharmacological Reports
    Article 31 October 2023
  18. Safety of non-standard regimen of systemic steroid therapy in patients with Graves’ orbitopathy: a single-centre experience

    Background

    Graves’ orbitopathy (GO) is an autoimmune disorder of the orbit and retro-ocular tissues and the primary extrathyroidal manifestation of...

    Nadia Sawicka-Gutaj, Dawid Gruszczyński, ... Marek Ruchała in Pharmacological Reports
    Article Open access 26 January 2024
  19. Hepatoprotective potential of 7,8-Dihydroxyflavone against alcohol and high-fat diet induced liver toxicity via attenuation of oxido-nitrosative stress and NF-κB activation

    Background : Fatty liver diseases are the most common and major health concern arises from the modern lifestyle and alcohol (ethanol) abuse. The...

    Dinesh Kumar, Durgesh Kumar Dwivedi, ... Ashok Jangra in Pharmacological Reports
    Article 08 July 2019
  20. Lipid-lowering drugs and cancer: an updated perspective

    Statins and non-statin medications used for the management of dyslipidemia have been shown to possess antitumor properties. Since the use of these...

    Azin Alizadehasl, Maryam Sadat Alavi, ... Amirhossein Sahebkar in Pharmacological Reports
    Article 28 November 2023
Did you find what you were looking for? Share feedback.